List view / Grid view
Center for Drug Evaluation and Research
Filter the results
Three API re-packers who failed to meet current good manufacturing practice requirements have received warning letters from the FDA.
The FDA has given its approval to a new injection for cluster headaches which reduce frequency of attacks.